Dimitrios Salgkamis

Articles

Journal article: ESMO OPEN. 2025;10:104574
20P Evolution of early-stage ERBB2-mutant, HER2+ breast cancer under neoadjuvant therapy
Wang K; Zerdes I; Sifakis EG; Salgkamis D; Bergh J; Hatschek T; Matikas A; Foukakis T
Article: IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS. 2024;28(9):5312-5322
Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology Images
Tsiknakis N; Manikis G; Tzoras E; Salgkamis D; Vidal JM; Wang K; Zaridis D; Sifakis E; Zerdes I; Bergh J; Hartman J; Acs B; Marias K; Foukakis T
Article: SCIENTIFIC REPORTS. 2024;14(1):18275
Systematic review and feasibility study on pre-analytical factors and genomic analyses on archival formalin-fixed paraffin-embedded breast cancer tissue
Salgkamis D; Sifakis EG; Agartz S; Wirta V; Hartman J; Bergh J; Foukakis T; Matikas A; Zerdes I
Article: NPJ BREAST CANCER. 2021;7(1):144
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study
Zerdes I; Simonetti M; Matikas A; Harbers L; Acs B; Boyaci C; Zhang N; Salgkamis D; Agartz S; Moreno-Ruiz P; Bai Y; Rimm DL; Hartman J; Mezheyeuski A; Bergh J; Crosetto N; Foukakis T

Review: DRUG DISCOVERY TODAY. 2025;30(1):104250
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
Filis P; Salgkamis D; Matikas A; Zerdes I

Clinical Assistant, Department of Oncology-Pathology, Karolinska Institutet, 2026-2026
Phd Student, Department of Oncology-Pathology, Karolinska Institutet, 2022-2026